//--> //--> //-->
Toggle navigation
Logout
Change account settings
EN
DE
ES
FR
A-Z
Beta
About EconBiz
News
Thesaurus (STW)
Research Skills
Help
EN
DE
ES
FR
My account
Logout
Change account settings
Login
Publications
Events
Your search terms
Search
Retain my current filters
type_genre:"Thesis"
~subject:"Pharmacology"
~type_genre:"Book section"
Search options
All Fields
Title
Exact title
Subject
Author
Institution
ISBN/ISSN
Published in...
Publisher
Open Access only
Advanced
Search history
My EconBiz
Favorites
Loans
Reservations
Fines
You are here:
Home
Search: subject_exact:"Medikament"
Narrow search
Delete all filters
| 3 applied filters
Year of publication
From:
To:
Subject
All
Pharmacology
Arzneimittel
548
Pharmaceuticals
539
Deutschland
147
Germany
144
Pharmaceutical industry
139
Pharmaindustrie
139
USA
74
United States
74
Gesundheitskosten
69
Health care costs
69
Arzneimittelmarkt
67
Pharmaceutical market
64
Gesundheitsversorgung
53
Health care
53
Welt
44
World
44
Innovation
42
Theorie
39
Theory
39
Pharmakologie
36
India
34
Indien
34
Gesetzliche Krankenversicherung
33
Public health insurance
32
Gesundheitspolitik
31
EU countries
30
EU-Staaten
30
Health policy
30
Regulierung
30
Preisregulierung
29
Price regulation
29
Regulation
26
Patent
25
Gesundheitswesen
24
Gesundheitsökonomik
23
Health economics
23
Hospital
23
Krankenhaus
23
Developing countries
22
more ...
less ...
Online availability
All
Free
3
Undetermined
2
Type of publication
All
Article
27
Book / Working Paper
9
Type of publication (narrower categories)
All
Thesis
Book section
Article in journal
179
Aufsatz in Zeitschrift
179
Graue Literatur
105
Non-commercial literature
105
Arbeitspapier
93
Working Paper
93
Aufsatz im Buch
27
Hochschulschrift
13
Collection of articles of several authors
12
Sammelwerk
12
Konferenzschrift
5
Aufsatzsammlung
4
Conference proceedings
4
Case study
3
Fallstudie
3
Amtliche Publikation
2
Bibliografie enthalten
2
Bibliography included
2
Bibliografie
1
Collection of articles written by one author
1
Elektronischer Datenträger
1
Glossar enthalten
1
Glossary included
1
Lehrbuch
1
Rezension
1
Sammlung
1
Textbook
1
more ...
less ...
Language
All
English
29
German
7
Author
All
Sonntag, Diana
3
Abrol, Dinesh
1
Bartelsman, Eric J.
1
Biehl, João
1
Campion, Marie-Geneviève
1
Chan, Tat
1
Combe, Emmanuel
1
Coriat, Benjamin
1
Eisen, Roland
1
Friedli, Thomas
1
Fueglistaller, Urs
1
Gerbsch, Norbert
1
Goldman, Dana P.
1
Graalmann, Jürgen
1
Grabowski, Henry
1
Harrington, Scott E.
1
Humphrey, Charlotte
1
Ilgin, Yasemin
1
Kappe, Eelco
1
Khachatourians, George K.
1
Kleinman, Arthur
1
Klug, Heinz
1
Kristic, Sabrina
1
Köbele, Walter
1
Lichtenberg, Frank R.
1
Lietz, Christine
1
Löwer, Johannes
1
Mahdi, Surya
1
Marchiodi, Ombretta
1
Marckmann, Georg
1
McGuire, Alistair
1
Möhrle, Jörg
1
Müller, Alejandro Cornejo
1
Müller-Langer, Frank
1
Narasimhan, Chakravarthi
1
Nightingale, Paul
1
Orsenigo, Luigi
1
Petryna, Adriana
1
Philipson, Tomas J.
1
Phillips, Peter W. B.
1
more ...
less ...
Institution
All
Julius-Maximilians-Universität Würzburg
1
Université de Paris
1
Published in...
All
The economics of new health technologies : incentives, organisation and financing
3
Bittere Arznei : Wirtschaftsethik und Ökonomik der pharmazeutischen Industrie
2
Global pharmaceuticals : ethics, markets, practices
2
Innovation and marketing in the pharmaceutical industry : emerging practices, research, and policies
2
Public goods, public policy and taxation : a European perspective
2
Access to medicines in India
1
Contributions to economics
1
Critical perspectives in public health
1
Das System der medizinischen Versorgung
1
ERIM Ph. D. series research in management / Erasmus Institute of Management
1
Effizienz, Qualität und Nachhaltigkeit im Gesundheitswesen : Theorie und Politik öffentlichen Handelns, insbesondere in der Krankenversicherung ; Festschrift zum 65. Geburtstag von Eberhard Wille
1
Gabler Research
1
Gabler Research / Ökonomische Analyse des Rechts
1
Governance, risk, and compliance handbook : technology, finance, environmental, and international guidance and best practices
1
Handbuch Market-Access : Marktzulassung ohne Nebenwirkungen
1
Intellectual property rights : legal and economic challenges for development
1
International public goods and transfer of technology under a globalized intellectual property regime
1
International trade and policies for genetically modified products
1
Internationale Wettbewerbsstrategien : die globale Wirtschaft und die Herausforderung China
1
Knowledge accumulation and industry evolution : the case of Pharma-Biotech
1
Market Access im Gesundheitswesen : Hürden und Zugangswege zur Gesundheitsversorgung
1
Measuring capital in the new economy
1
Regulation versus litigation : perspectives from economics and law
1
The Oxford handbook of the economics of the biopharmaceutical industry
1
Was ist uns die Gesundheit wert? : gerechte Verteilung knapper Ressourcen ; Beiträge des Symposiums vom 10. bis 13. September 2006 in Cadenabbia
1
more ...
less ...
Source
All
ECONIS (ZBW)
36
Showing
1
-
36
of
36
Sort
Relevance
Date (newest first)
Date (oldest first)
1
Können die Preise für neue Medikamente sinken?
Müller, Alejandro Cornejo
;
Rödiger, Tim
;
Graalmann, …
- In:
Market Access im Gesundheitswesen : Hürden und …
,
(pp. 209-237)
.
2020
Persistent link: https://www.econbiz.de/10012194823
Saved in:
2
Competition between originators and generics : public regulation and incentives to innovate
Campion, Marie-Geneviève
-
2015
The aim of this thesis is to examine the competition patterns that exist between originators and generics by focusing on the articulations between regulation and incentives to innovate. Once the characteristics of regulation in pharmaceutical markets is reviewed in the first chapter and an...
Persistent link: https://www.econbiz.de/10011432290
Saved in:
3
Managing integrated development in the pharmaceutical industry : a cross-functional approach to development of more efficient manufacturing processes
Ziegler, Reto Marc
-
2014
Aktuelle Zahlen aus der pharmazeutischen Industrie zeigen, dass die Entwicklung von neuen Produkten immer länger dauert und immer mehr kostet. Zudem schaffen immer weniger Produkte die Hürde der klinischen Entwicklung. Man spricht schon fast von einem Produktivitätsproblem der Forschung und...
Persistent link: https://www.econbiz.de/10010256239
Saved in:
4
Innovation paradox in vaccine target selection
Pronker, Esther Sophia
-
2013
Persistent link: https://www.econbiz.de/10009738384
Saved in:
5
The empirical application of real options and corporate competencies to research and development in the pharmaceutical industry
Marchiodi, Ombretta
-
2014
Persistent link: https://www.econbiz.de/10011437318
Saved in:
6
IPRs, public health and the pharmaceutical industry : issues in the post-2005 TRIPS agenda
Coriat, Benjamin
;
Orsenigo, Luigi
- In:
Intellectual property rights : legal and economic …
,
(pp. 219-241)
.
2014
Persistent link: https://www.econbiz.de/10010354866
Saved in:
7
Recent trends in India's pharmaceutical innovation
Abrol, Dinesh
;
Prajapati, Pramod
;
Singh, Nidhi
- In:
Access to medicines in India
,
(pp. 165-206)
.
2014
Persistent link: https://www.econbiz.de/10010463454
Saved in:
8
Pharmaceutical lifecycle extension strategies
Kappe, Eelco
- In:
Innovation and marketing in the pharmaceutical industry …
,
(pp. 225-254)
.
2014
Persistent link: https://www.econbiz.de/10010353564
Saved in:
9
Evaluating the impact of treatment effectiveness and side effects in presribing choices
Chan, Tat
;
Narasimhan, Chakravarthi
;
Xie, Ying
- In:
Innovation and marketing in the pharmaceutical industry …
,
(pp. 171-187)
.
2014
Persistent link: https://www.econbiz.de/10010353576
Saved in:
10
Anreizkompatible Regulierung des Wettbewerbs in den verschiedenen Marktphasen einer pharmazeutischen Innovation
Kristic, Sabrina
-
2013
Persistent link: https://www.econbiz.de/10011413922
Saved in:
11
Arzneimittelversorgung
Schulte, Ansgar
;
Löwer, Johannes
;
Schwerdtfeger, Walter K.
-
2012
Persistent link: https://www.econbiz.de/10009515785
Saved in:
12
Cost of Capital for Pharmaceutical, Biotechnology, and Medical Device Firms
Harrington, Scott E.
- In:
The Oxford handbook of the economics of the …
.
2012
Persistent link: https://www.econbiz.de/10012881697
Saved in:
13
Hürdenlauf zum Markt für neue Medikamente? : von Nutzen und Risiken für Unternehmer
Wegener, Bernd
;
Lietz, Christine
;
Gerbsch, Norbert
- In:
Handbuch Market-Access : Marktzulassung ohne Nebenwirkungen
,
(pp. 105-124)
.
2011
Persistent link: https://www.econbiz.de/10008859755
Saved in:
14
The effects of product liability exemption in the presence of the FDA
Philipson, Tomas J.
;
Sun, Eric
;
Goldman, Dana P.
- In:
Regulation versus litigation : perspectives from …
,
(pp. 137-163)
.
2011
Persistent link: https://www.econbiz.de/10009236132
Saved in:
15
AIDS and aid : a public good approach
Sonntag, Diana
-
2010
Persistent link: https://www.econbiz.de/10003929594
Saved in:
16
Clinical trial excellence in the pharmaceutical industry : an integrated management model
Volkmer, Niels-Christian
-
2010
Persistent link: https://www.econbiz.de/10008936034
Saved in:
17
Diffusion of health technologies : evidence from the pharmaceutical sector
Serra-Sastre, Victoria
;
McGuire, Alistair
- In:
The economics of new health technologies : incentives, …
,
(pp. 53-71)
.
2009
Persistent link: https://www.econbiz.de/10003915931
Saved in:
18
Ageing and pharmaceutical innovation
Eisen, Roland
;
Ilgin, Yasemin
- In:
The economics of new health technologies : incentives, …
,
(pp. 149-157)
.
2009
Persistent link: https://www.econbiz.de/10003915982
Saved in:
19
Intellectual property rights and pharmaceutical development
Rovira Forns, Joan
- In:
The economics of new health technologies : incentives, …
,
(pp. 219-239)
.
2009
Persistent link: https://www.econbiz.de/10003916101
Saved in:
20
Providing global public goods against AIDS : the role of aggregation technologies
Sonntag, Diana
- In:
Public goods, public policy and taxation : a European …
,
(pp. 57-70)
.
2009
Persistent link: https://www.econbiz.de/10003893910
Saved in:
21
Financing Vaccine research in developing countries : a public good approach
Sonntag, Diana
- In:
Public goods, public policy and taxation : a European …
,
(pp. 71-85)
.
2009
Persistent link: https://www.econbiz.de/10003893911
Saved in:
22
Creating R&D incentives for medicines for neglected diseases : an economic analysis of parallel imports, patents, and alternative mechanisms to stimulate pharmaceutical research
Müller-Langer, Frank
-
2009
-
1. ed.
Persistent link: https://www.econbiz.de/10003821967
Saved in:
23
Pharmaceutical
Robertson, James G.
- In:
Governance, risk, and compliance handbook : technology, …
,
(pp. 475-484)
.
2008
Persistent link: https://www.econbiz.de/10003691595
Saved in:
24
Antibiotic resistance : an exemplary case of medical nemesis
Humphrey, Charlotte
- In:
Critical perspectives in public health
,
(pp. 213-218)
.
2008
Persistent link: https://www.econbiz.de/10003700051
Saved in:
25
Ausrichtung von Forschung und Entwicklung in der Pharmaindustrie : keine Chance für seltene und Dritte-Welt-Erkrankungen?
Marckmann, Georg
- In:
Bittere Arznei : Wirtschaftsethik und Ökonomik der …
,
(pp. 71-82)
.
2008
Persistent link: https://www.econbiz.de/10003624109
Saved in:
26
Vermarktung von Arzneimittelpatenten
Reepmeyer, Gerrit
- In:
Bittere Arznei : Wirtschaftsethik und Ökonomik der …
,
(pp. 183-208)
.
2008
Persistent link: https://www.econbiz.de/10003624150
Saved in:
27
German drug pricing policy : a critical comment
Schulenburg, Johann-Matthias von der
- In:
Effizienz, Qualität und Nachhaltigkeit im …
,
(pp. 565-577)
.
2007
Persistent link: https://www.econbiz.de/10003511582
Saved in:
28
Strategies to improve access to anti-malarial drugs
Möhrle, Jörg
- In:
Internationale Wettbewerbsstrategien : die globale …
,
(pp. 233-253)
.
2007
Persistent link: https://www.econbiz.de/10003578536
Saved in:
29
Medizinisch-pharmazeutische Innovationen und ihre Auswirkungen auf die Gesundheitsausgaben
Köbele, Walter
- In:
Was ist uns die Gesundheit wert? : gerechte Verteilung …
,
(pp. 84-96)
.
2007
Persistent link: https://www.econbiz.de/10003554970
Saved in:
30
The pharmaceutical nexus
Petryna, Adriana
;
Kleinman, Arthur
- In:
Global pharmaceuticals : ethics, markets, practices
,
(pp. 1-32)
.
2006
Persistent link: https://www.econbiz.de/10003415449
Saved in:
31
Pharmaceutical governance
Biehl, João
- In:
Global pharmaceuticals : ethics, markets, practices
,
(pp. 206-239)
.
2006
Persistent link: https://www.econbiz.de/10003415524
Saved in:
32
The evolution of pharmaceutical innovation
Nightingale, Paul
;
Mahdi, Surya
- In:
Knowledge accumulation and industry evolution : the …
,
(pp. 73-111)
.
2006
Persistent link: https://www.econbiz.de/10003402117
Saved in:
33
Governing innovative science : challenges facing the commercialization of plant-made pharmaceuticals
Smyth, Stuart
;
Khachatourians, George K.
;
Phillips, …
- In:
International trade and policies for genetically …
,
(pp. 133-146)
.
2006
Persistent link: https://www.econbiz.de/10003326914
Saved in:
34
Three essays on the economics of health and development
Yin, Wesley
-
2005
Persistent link: https://www.econbiz.de/10003380907
Saved in:
35
Pharmaceutical knowledge-capital accumulation and longevity
Lichtenberg, Frank R.
- In:
Measuring capital in the new economy
,
(pp. 237-269)
.
2005
Persistent link: https://www.econbiz.de/10003080944
Saved in:
36
Increasing R&D incentives for neglected diseases : lessons from the Orphan Drug Act
Grabowski, Henry
- In:
International public goods and transfer of technology …
,
(pp. 425-456)
.
2005
Persistent link: https://www.econbiz.de/10003414416
Saved in:
Results per page
10
25
50
100
250
A service of the
zbw
×
Loading...
//-->